ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "OMERACT"

  • Abstract Number: 0200 • ACR Convergence 2022

    Should Independence Play a Role in Assessing Remission in Rheumatoid Arthritis?

    Thomas Khoo1, Bethan Jones2, Athena Chin1, Alice Terrett3, Marieke Voshaar4, Wijnanda Hoogland5, Lyn March6, Dorcas Beaton7, Ummugulsum Gazel8, Beverley Shea9, Peter Tugwell10, Caroline Flurey11 and Susanna Proudman12, 1Rheumatology Unit, Flinders Medical Centre, Adelaide, Australia, 2School of Healthcare and Social Wellbeing, University of the West of England, Bristol, United Kingdom, 3Rheumatology Unit, The Royal Adelaide Hospital, Adelaide, Australia, 4Department of Pharmacy and Department of Research & Innovation, Sint Maartenskliniek and Department of Pharmacy, Radboud University Medical Centre, Nijmegan, Netherlands, 5OMERACT Patient Research Partner, Netherlands, 6Sydney Medical School, Institute of Bone and Joint Research, and Department of Rheumatology, Royal North Shore Hospital, St. Leonards, Australia, 7Institute for Work & Health, Toronto, ON, Canada, 8University of Ottawa, Rheumatology, Ottawa, Canada, Ottawa, ON, Canada, 9School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada, Ottawa, Canada, 10University of Ottawa, Ottawa, Canada, Ottawa, ON, Canada, 11Faculty of Health and Applied Sciences, University of the West of England, Bristol, United Kingdom, 12Rheumatology Unit, Royal Adelaide Hospital, and Discipline of Medicine, University of Adelaide, Adelaide, Australia

    Background/Purpose: The current goal of treatment in rheumatoid arthritis (RA) is clinical remission, which according to the ACR/EULAR 2011 definition, is based on tender and…
  • Abstract Number: 0217 • ACR Convergence 2022

    Where Are the Reporting Guidelines in Rheumatology? An Analysis of Their Use in over 850 Published Manuscripts

    Aldo Barajas-Ochoa1, Antonio Cisneros-Barrios2, Manuel Ramirez-Trejo2 and Cesar Ramos-Remus3, 1Rutgers New Jersey Medical School., Richmond, VA, 2Universidad de Guadalajara, Guadalajara, Mexico, 3Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico

    Background/Purpose: EQUATOR-related reporting guidelines such as CONSORT, STROBE, and PRISMA have been said to promote clearer reporting of methods and results of a research manuscript…
  • Abstract Number: 0761 • ACR Convergence 2022

    Identification of Outcome Domains in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis and Polymyalgia Rheumatica: A Scoping Review by the OMERACT IrAE Working Group

    Nilasha Ghosh1, Nina Couette2, Wouter van Binsbergen3, Sophia Weinmann4, Bridget Jivanelli1, Beverley Shea5, Anne Bass6, Karolina Benesova7, Clifton O. Bingham III8, Cassandra Calabrese9, Laura C. Cappelli10, Karmela Kim Chan1, Ernest Choy11, Dimitrios Daoussis12, Susan Goodman1, Marie Hudson13, Shahin Jamal14, Jan Leipe15, Maria A. Lopez-Olivo16, Maria Suarez-Almazor17, Conny van der Laken18, Alexa Meara19, David Liew20 and Marie Kostine21, 1Hospital for Special Surgery, New York, NY, 2Department of Internal Medicine. Division of Rheumatology & Immunology, The Ohio State University, Columbus, OH, 3Amsterdam Rheumatology and Immunology Center, Department of Rheumatology & Clinical Immunology, Amsterdam University Medical Center location DBL, Amsterdam, Netherlands, 4Department of Rheumatology & Immunology, Duke University, Durham, NC, 5School of Epidemiology and Public Health, University of Ottawa, Ottawa, 6Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 7University Hospital Heidelberg, Heidelberg, Germany, 8Johns Hopkins University, Baltimore, MD, 9Cleveland Clinic Foundation, Cleveland Heights, OH, 10Johns Hopkins School of Medicine, Baltimore, MD, 11Division of Infection and Immunity, CREATE Centre, Cardiff University, Cardiff, Wales, United Kingdom, 12Department of Rheumatology, University of Patras Medical School, Patras University Hospital, Patras, Greece, 13McGill University, Montréal, QC, Canada, 14University of British Columbia, Vancouver, BC, Canada, 15Division of Rheumatology, Department of Medicine V, University Hospital Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany, 16The University of Texas, MD Anderson Cancer Center, Houston, TX, 17MD Anderson Cancer Center, Houston, TX, 18Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Centers – location VUMC, Amsterdam, Netherlands, 19The Ohio State University Wexner Medical Center, Columbus, OH, 20Austin Health, Heidelberg, Australia, 21Pellegrin Hospital, University Hospital of Bordeaux, Rheumatology, Bordeaux, France

    Background/Purpose: Immune checkpoint inhibitors (ICI), increasingly used cancer therapeutics, can cause off-target inflammatory effects called immune-related adverse events (irAEs), including ICI-induced inflammatory arthritis (ICI-induced IA)…
  • Abstract Number: 0906 • ACR Convergence 2022

    Patients with Seronegative Rheumatoid Arthritis Have a Different Ultrasound-assessed Joint Disease Phenotype Than Seropositive Patients

    Natalia Carbonell-Bobadilla1, Carina Soto-Fajardo2, Luis M Amezcua-Guerra3, Ana Beatriz Batres Marroquin4, Ana Cristina Medina5, Tania Vargas3, Adrián Hernández-Diazcouder3, Valentín Jiménez-Rojas3, Carlos Pineda5 and Luis H Silveira6, 1National Institute of Cardiology Ignacio Chávez, Ciudad de México, Mexico, 2Instituto Nacional de Rehabilitacion "Luis Guillermo Ibarra Ibarra", Ciudad de México, Mexico, 3Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico, 4Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, Mexico, 5Instituto Nacional de Rehabilitacion, Ciudad de México, Mexico, 6Instituto Nacional de Cardiología, Ciudad de México, Mexico

    Background/Purpose: Seronegative rheumatoid arthritis (SNRA) tends to be less severe in its presentation and evolution than seropositive rheumatoid arthritis(SPRA), but controversy exists because there have…
  • Abstract Number: 1254 • ACR Convergence 2022

    Ultra High‐Frequency Ultrasound of Labial Salivary Glands in Primary Sjögren’s Syndrome: A Promising Tool to Identify Lymphoproliferative Lesions in Unusual Sites

    Giovanni Fulvio1, Rossana Izzetti2, Francesco Ferro3, Gianmaria Governato4, Gaetano La Rocca5, Silvia Fonzetti6, Inmaculada Concepción Navarro García7, Marta Mosca8, Valentina Donati9 and Chiara Baldini1, 1University of Pisa, Pisa, Pisa, Italy, 2Unit of Dentistry and Oral Surgery, Pisa, Toscana, Italy, 3Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Pisa, Italy, 4Azienda Ospedaliera Universitaria Pisana, Pisa, Pisa, Italy, 5University of Pisa, Rheumatology Unit, Palermo, Palermo, Italy, 6Azienda Ospedaliera Universitaria Pisana, Pisa, Italy, 7Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy, 8Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 9Pathology Unit, University of Pisa, Pisa, Italy

    Background/Purpose: Major salivary gland (MSG) ultrasound (US) is a useful tool in Sjögren's syndrome (SS) diagnostic work-up. Interestingly, in a recent case series, specific US…
  • Abstract Number: 2079 • ACR Convergence 2022

    Survey to Prioritize and Generate Domains in Preparation to Update the OMERACT Core Domain Set for Systemic Lupus Erythematosus

    Wils Nielsen1, Vibeke Strand2, Lee S Simon3, Julian Thumboo4, Marta Mosca5, Martin Aringer6, Sindu Johnson7, Aaron Drucker7, Eric Morand8, Ian N. Bruce9 and Zahi Touma1, 1Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 2Stanford University School of Medicine, Stanford, CA, 3SDG LLC, West Newton, MA, 4Singapore General Hospital, Bukit Merah, Singapore, 5Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 6University Medical Center and Faculty of Medicine TU Dresden, Dresden, Germany, 7University of Toronto, Toronto, ON, Canada, 8Monash University, Victoria; Department of Rheumatology, Monash Health, Melbourne, Australia, 9Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: The development of a Core Outcome domain Set (COS) can aid research communication and standardizing measurement tools of SLE. A COS captures SLE facets…
  • Abstract Number: 2141 • ACR Convergence 2022

    How Well Does Ultrasound-assessed Synovitis in Reduced Joint Sets Predict the Response to Secukinumab in Patients with Active Psoriatic Arthritis and Inadequate Response to Conventional DMARDs? – Exploratory Results from a Phase 3b Study

    Maria-Antonietta D'Agostino1, Philip G Conaghan2, Corine Gaillez3, Esperanza Naredo4, Peter mandl5, Philippe Carron6, Ladislav Šenolt7, Javier Eduardo Rosa8, Alejandra Lopez Rdz9, Punit Goyanka10, Braja Gopal Sahoo10, Weibin Bao11, Georg Schett12 and Maarten Boers13, 1Catholic University of Sacred Heart, Roma, Italy, 2University of Leeds, Leeds, United Kingdom, 3Novartis Pharma AG, Basel, Switzerland, 4Hospital General Universitario Gregorio Marañón and Complutense University, Madrid, Spain, 5Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Wien, Austria, 6Ghent University Hospital, Ghent, Belgium, 7Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 8Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 9Dermatológico Country, PSOAPS Psoriasis Clinical and Research Centre, Guadalajara, Mexico, 10Novartis Healthcare Pvt Ltd, Hyderabad, India, 11Novartis Pharmaceuticals Corporation, East Hanover, NJ, 12Universitätsklinikum Erlangen, Erlangen, Germany, 13Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands

    Background/Purpose: Power Doppler ultrasound (PDUS) allows the visualization of morphological and inflammatory changes of the synovium. The ULTIMATE study (NCT02662985) was the first large, randomized,…
  • Abstract Number: 2208 • ACR Convergence 2022

    Diagnostic Performance of Hip Ultrasound in Calcium Pyrophosphate Deposition Disease

    Carina Soto-Fajardo1, Fabian Carranza-Enriquez2, Sinthia Solorzano Flores2, Abish Angeles2, Paola Flores2, Raul Pichardo-Bahena2, Luis Javier Jara Quezada2, Angélica Peña Ayala2, Victor-Manuel Ilizaliturri-Sanchez2, Georgios Filippou3 and Carlos Pineda2, 1Instituto Nacional de Rehabilitacion "Luis Guillermo Ibarra Ibarra", Ciudad de México, Mexico, 2Instituto Nacional de Rehabilitacion, Ciudad de México, Mexico, 3Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy

    Background/Purpose: Calcium Pyrophosphate Deposition Disease (CPPD) is a chronic and potentially incapacitating disease. The reference standard for its diagnosis is the identification of calcium pyrophosphate…
  • Abstract Number: 0726 • ACR Convergence 2021

    Joint Safety of Tanezumab versus NSAIDs; A Combined Assessment of Benefit and Harm

    Robert Fountaine1, Robert Dworkin2, Anne Hickman1, Glenn Pixton3, Ed Whalen4, Christine West1 and Kenneth Verburg1, 1Pfizer Inc., Groton, CT, 2University of Rochester, Rochester, NY, 3Pfizer Inc., Morrisville, NC, 4Pfizer Inc., New York, NY

    Background/Purpose: Tanezumab, a monoclonal antibody against nerve growth factor, is in development for the relief of signs and symptoms of moderate to severe osteoarthritis (OA)…
  • Abstract Number: 1358 • ACR Convergence 2021

    Clusters of Psoriatic Arthritis Patients at Baseline Based on Different Ultrasound Detected Synovitis: Exploratory Analysis from a Phase III Study

    Maria Antonietta D'Agostino1, Georg Schett2, Corine Gaillez3, Philip Conaghan4, Esperanza Naredo5, Philippe Carron6, Ruben Burgos-Vargas7, Peter Mandl8, Javier Rosa9, Maarten Boers10, Punit Goyanka11, Weibin Bao12 and David Demanse3, 1Rheumatology, Fondazione Policlinico Universitario “Gemelli”, IRCCS, Rome, Italy, 2Universitätsklinikum Erlangen, Department of Internal Medicine 3 – Rheumatology and Immunology, Erlangen, Germany, Erlangen, Germany, 3Novartis Pharma AG, Basel, Switzerland, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 5Department of Rheumatology and Joint and Bone Research Unit, Hospital Fundación Jiménez Díaz and Autónoma University, Madrid, Spain, 6Department of Rheumatology, University Hospital Ghent, University of Ghent, Ghent, Belgium, 7Department of Rheumatology, General Hospital of Mexico, Ciudad de Mxico, Mexico, 8Medical University of Vienna, Vienna, Austria, 9Rheumatology Unit, Internal Medical Services, and University Institute, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 10Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands, 11Novartis Healthcare Pvt Ltd, Hyderabad, India, Hyderabad, India, 12Novartis, East Hanover, NJ

    Background/Purpose: Psoriatic arthritis (PsA) is characterized by inflammation of synovial membranes and entheseal sites leading to pain, structural damage, impairment of physical function and quality…
  • Abstract Number: 1582 • ACR Convergence 2021

    Diagnostic Accuracy and Reliability of Conventional Radiography of the Knee in Calcium Pyrophosphate Deposition Disease by Using New Definitions: An Ancillary Study of the OMERACT Ultrasound – CPPD Group

    Silvia Sirotti1, Fabio Becce2, Luca Maria Sconfienza3, Carlos Pineda4, Marwin Gutierrez5, Teodora Serban6, Daryl MacCarter7, Antonella Adinolfi8, Anna Scanu9, Carlo Alberto Scire10, Ingrid Moller11, Esperanza Naredo12, Piercarlo Sarzi-Puttini13, Abhishek Abhishek14, Hyon K. Choi15, Nicola Dalbeth16, Sara Tedeschi17, Maria-Antonietta D'Agostino18, Nemanja Damjanov19, Helen Keen20, Lene Terslev21, Annamaria Iagnocco22 and Georgios Filippou23, 1Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy, 2Lausanne University Hospital, Lausanne, Switzerland, 3Department of Biomedical Sciences for Health, Università Degli Studi di Milano, Milan, Italy, 4Instituto Nacional de Rehabilitacion, Mexico City, Federal District, Mexico, 5Division of Musculoskeletal and Rheumatic Diseases, Instituto Nacional de Rehabilitacion, Mexico City, Mexico, 6Ospedale La Colletta, ASL3 Genovese, Genoa, Italy, 7Rheumatology Department, North Valley Hospital, Whitefish, MT, 8Rheumatology Unit, Grande Ospedale Metropolitano Niguarda, Milan, Italy, 9Department of Medicine-DIMED, Rheumatology Unit, University of Padova, Padoa, Italy, 10SIR Epidemiology, Research Unit, Pavia, Italy, 11University of Barcelona, Barcelona, Spain, 12Department of Rheumatology and Joint and Bone Research Unit, Hospital Fundación Jiménez Díaz and Autónoma University, Madrid, Spain, 13Rheumatology Department, Luigi Sacco University Hospital, Milano, Italy, 14University of Nottingham, Nottingham, United Kingdom, 15Massachusetts General Hospital, Lexington, MA, 16University of Auckland, Auckland, New Zealand, 17Brigham and Women's Hospital, Boston, MA, 18Rheumatology Department, Università Cattolica del Sacro Cuore, Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy, 19University of Belgrade School of Medicine, Institute of Rheumatology, Belgrade, Serbia, 20University of Western Australia, Daglish, Australia, 21Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University, Glostrup, Denmark, 22University of Turin, Roma, Italy, 23Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy

    Background/Purpose: Conventional Radiography (CR) has been widely used in Calcium Pyrophosphate Deposition Disease (CPPD) and is considered an important tool for the diagnosis. However, there…
  • Abstract Number: 1583 • ACR Convergence 2021

    Creation of an Ultrasonographic Scoring System for CPPD Extent: Results from a Delphi Process by the OMERACT US Working Group – CPPD Subgroup

    Silvia Sirotti1, Antonella Adinolfi2, Fabio Becce3, Tomas Cazenave4, Sara Nysom Christiansen5, Edoardo Cipolletta6, Andrea Delle Sedie7, Mario Enrique Diaz Cortes8, Fabiana Figus9, Emilio Filippucci10, Peter Mandl11, Daryl MacCarter12, Ingrid Moller13, Mohamed Mortada14, Gael Mouterde15, Maria Esperanza Naredo Sanchez16, Carlos Pineda17, Francesco Porta18, Wolfgang Schmidt19, Teodora Serban20, Lene Terslev21, Florentin Vreju22, Richard Wakefield23, Pascal Zufferey24, Piercarlo Sarzi-Puttini25, Maria-Antonietta D'Agostino26, Nemanja Damjanov27, Annamaria Iagnocco28, Helen Keen29 and Georgios Filippou30, 1Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy, 2Rheumatology Unit, Grande Ospedale Metropolitano Niguarda, Milan, Italy, 3Lausanne University Hospital, Lausanne, Switzerland, 4Instituto de Rehabilitación Psicofisica, Buenos Aires, Argentina, Buenos Aires, Argentina, 5Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, 6Polytechnic University of Marche, Jesi, Italy, 7University of Pisa, Pisa, Italy, 8Rheumatology Unit, University Hospital Fundación Santa Fe de Bogota, Bogotà, Colombia, 9University of Torino, Torino, Italy, 10Rheumatology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Jesi, Italy, 11Medical University of Vienna, Vienna, Austria, 12Rheumatology Department, North Valley Hospital, Whitefish, MT, 13University of Barcelona, Barcelona, Spain, 14Zagazig University, Zagazig, Egypt, 15Rheumatology department, CHU Montpellier, Montpellier, France, 16Department of rheumatology, Joint and Bone research Unit, Hospital Universitario Fundación Jiménez díaz and Autónoma University, Madrid, Spain, 17Instituto Nacional de Rehabilitacion, Mexico City, Federal District, Mexico, 18INS, Institute of Neurosciences, Florence, Italy, 19Immanuel Krankenhaus Berlin, Berlin, Germany, 20ASL 3 Genovese, Genova, Italy, 21Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University, Glostrup, Denmark, 22Rheumatology Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania, 23Rheumatology, Leeds University, Leeds, United Kingdom, 24Rheumatology Department, University of Lausanne, CHUV, Lausanne, Switzerland, 25L.Sacco University Hospital, Milano, Italy, 26Rheumatology Department, Università Cattolica del Sacro Cuore, Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy, 27University of Belgrade School of Medicine, Institute of Rheumatology, Belgrade, Serbia, 28University of Turin, Roma, Italy, 29University of Western Australia, Daglish, Australia, 30Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy

    Background/Purpose: Ultrasound (US) has proven to be an excellent technique for detecting Calcium Pyrophosphate (CPP) deposits, however there are no grading systems that allow for…
  • Abstract Number: 1886 • ACR Convergence 2020

    Measuring Physical Activity in AxSpA:Content Validity and Measurement Properties of the New AxSpA-SQUASH

    Marllies Carbo1, Davy Paap2, Fiona Maas1, Mark Siderius3, Hendrika Bootsma1, Freke Wink3, Suzanne Arends3 and Anneke Spoorenberg3, 1University Medical Centre Groningen, Groningen, Netherlands, 2, Department of Rehabilitation Medicine, University of Medical Centre Groningen, Groningen, Netherlands, 3University Medical Centre Groningen and Medical centre Leeuwarden, Groningen, Netherlands

    Background/Purpose: The ASAS-EULAR recommendations for management of axial Spondyloarthritis (axSpA) includes that patients should be encouraged to exercise. There is no validated instrument for measuring…
  • Abstract Number: 1939 • ACR Convergence 2020

    Definitions and Reliability Assessment of Chronic Ultrasound Lesions of the Axillary Artery in Giant Cell Arteritis: A Study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group

    Valentin Schaefer1, Stavros Chrysidis2, Greta Carrara3, Wolfgang Schmidt4, George A. Bruyn5, Bhaskar Dasgupta6, Eugenio De Miguel7, Andreas Diamantopoulos8, Christina Duftner9, Ulrich Fredberg10, Berit Nielsen11, Wolfgang Hartung12, Alojzija Hocevar13, Annamaria Iagnocco14, Aaron Juche4, Tanaz Kermani15, Tove Lorenzen16, Pierluigi Macchioni17, Marcin Milchert18, Uffe Døhn19, Sara Monti20, Chetan Mukhtyar21, Cristina Ponte22, Carlo Scire23, Lene Terslev24, Luca Seitz25 and Christian Dejaco26, 1Clinic of Internal Medicine III, Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Germany, Bonn, Nordrhein-Westfalen, Germany, 2Sydvestjysk Sygehus Esbjerg, Esbjerg, Denmark, 3Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy, 4Immanuel Krankenhaus Berlin Buch, Berlin, Germany, 5Rheumatology, Reumakliniek Lelystad, Lelystad, Netherlands, 6Rheumatology, Mid and South Essex University Hospital NHS Foundation Trust, Southend University Hospital, United Kingdom, Westcliff on sea, England, United Kingdom, 7Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain, 8Martina Hansens Hospital, Baerum, Norway, 9Medical University Innsbruck, Innsbruck, Austria, 10Silkeborg Regional Hospital, Silkeborg, Denmark, 11Aarhus University Hospital, Aarhus, Denmark, 12Asklepios Klinik Bad Abbach, Bad Abbacg, Germany, 13University Medical Center, Rheumatology, Ljubljana, LJUBLJANA, Slovenia, 14Università degli Studi di Torino, Academic Rheumatology Centre, Turin, Italy, 15David Geffen School of Medicine / University of California, Los Angeles, CA, 16Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 17Unità Operativa di Reumatologia/Arcispedale S. Maria Nuova, Reggio Emilia, Italy, 18Pomeranian Medical University, Szczecin, Poland, 19Center for Rheumatology and Spine Diseasesand COPECARE, Copenhagen, Denmark, 20Fondazione IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy, 21Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom, 22Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal, 23University of Ferrara, Ferrara, Italy, 24Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup., Copenhagen, Denmark, 25Department of Rheumatology, Immunology and Allergology, University of Bern, Inselspital, Switzerland, Bern, Switzerland, 26South Tyrol Health Trust, Hospital of Bruneck, Bruneck, Italy

    Background/Purpose: The OMERACT Ultrasound (US) large vessel vasculitis task force has recently defined the US appearance of normal axillary arteries (AA) and the key elementary…
  • Abstract Number: 0921 • ACR Convergence 2020

    The Hospital Anxiety and Depression Scale in Patients with Systemic Sclerosis – A Psychometric and Factor Analysis in a Monocentric Cohort

    Alexandru Garaiman1, Carina Mihai1, Rucsandra Dobrota1, Suzana Jordan1, Britta Maurer2, Jan Flemming3, Oliver Distler4 and Mike Oliver Becker1, 1Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, Zurich, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Switzerland, Zurich, 3Department of Consultation-Liaison-Psychiatry and Psychosomatic Medicine, University Hospital Zurich, Zurich, Switzerland, Zurich, Switzerland, 4Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, Switzerland, Zurich, Switzerland

    Background/Purpose: The Hospital Anxiety and Depression Scale (HADS) is a screening tool used in patients with different medical conditions. However, its validity, reliability and responsiveness…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology